Sathyasaikumar, K.V.; Notarangelo, F.M.; Kelly, D.L.; Rowland, L.M.; Hare, S.M.; Chen, S.; Mo, C.; Buchanan, R.W.; Schwarcz, R.
Tryptophan Challenge in Healthy Controls and People with Schizophrenia: Acute Effects on Plasma Levels of Kynurenine, Kynurenic Acid and 5-Hydroxyindoleacetic Acid. Pharmaceuticals 2022, 15, 1003.
https://doi.org/10.3390/ph15081003
AMA Style
Sathyasaikumar KV, Notarangelo FM, Kelly DL, Rowland LM, Hare SM, Chen S, Mo C, Buchanan RW, Schwarcz R.
Tryptophan Challenge in Healthy Controls and People with Schizophrenia: Acute Effects on Plasma Levels of Kynurenine, Kynurenic Acid and 5-Hydroxyindoleacetic Acid. Pharmaceuticals. 2022; 15(8):1003.
https://doi.org/10.3390/ph15081003
Chicago/Turabian Style
Sathyasaikumar, Korrapati V., Francesca M. Notarangelo, Deanna L. Kelly, Laura M. Rowland, Stephanie M. Hare, Shuo Chen, Chen Mo, Robert W. Buchanan, and Robert Schwarcz.
2022. "Tryptophan Challenge in Healthy Controls and People with Schizophrenia: Acute Effects on Plasma Levels of Kynurenine, Kynurenic Acid and 5-Hydroxyindoleacetic Acid" Pharmaceuticals 15, no. 8: 1003.
https://doi.org/10.3390/ph15081003
APA Style
Sathyasaikumar, K. V., Notarangelo, F. M., Kelly, D. L., Rowland, L. M., Hare, S. M., Chen, S., Mo, C., Buchanan, R. W., & Schwarcz, R.
(2022). Tryptophan Challenge in Healthy Controls and People with Schizophrenia: Acute Effects on Plasma Levels of Kynurenine, Kynurenic Acid and 5-Hydroxyindoleacetic Acid. Pharmaceuticals, 15(8), 1003.
https://doi.org/10.3390/ph15081003
